(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes - 2U.S. overhauls childhood vaccine schedule, recommends fewer shots
- 3The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
- 4Venezuelans in Madrid celebrate Maduro's capture
- 5Becoming Familiar with an Unknown dialect: My Language Learning Excursion
- Ferrari Cavalcade Suspended After High-Speed Crash in Argentina Involving a Purosangue
- Novartis eyes more bolt-on acquisitions, CEO says
- The most effective method to Go with Informed Choices on Vehicle Leases
- 6 Famous Urban communities for Shopping on the planet
- $2,000 tariff rebate checks? 50-year mortgages? Making sense of Trump's new 'affordability' proposals.
- ‘It’s Israeli policy’: Report reveals abuse of Palestinians in prisons
- Seven deaths possibly linked to malfunctioning glucose monitors
- Agricultural drones are taking off globally, saving farmers time and money
- The Magnificence of Do-It-Yourself Skincare: Regular Recipes and Tips
